INHIBITING MIR-10A OVERCOMES CYTARABINE-RESISTANCE IN ACUTE MYELOID LEUKAEMIA

被引：0
|
作者：
Vu, T. T. [1 ]
Wang, K. [1 ]
Stoelzel, F. [2 ]
Ehninger, G. [2 ]
Molloy, T. [1 ]
Ma, D. [1 ]
机构：
[1] St Vincents Hosp, Haematol, Sydney, NSW, Australia
[2] Univ Hosp Carl Gustav Carus, Med Clin & Policlin 1, Dresden, Germany
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E880
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [41] Petechiae, suffusions and cytarabine-induced erythema in the treatment of acute myeloid leukaemia
    Taverna, C
    Jacky, E
    Sauter, C
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1998, 128 (27-28) : 1117 - 1117
  • [42] Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia
    Gaur, Tarang
    Ali, Ahlam
    Sharma, Deepak
    Gupta, Saurabh Kumar
    Gota, Vikram
    Bagal, Bhausaheb
    Platzbeckar, Uwe
    Mishra, Rohit
    Dutt, Amit
    Khattry, Navin
    Mills, Ken
    Hassan, Md. Imtaiyaz
    Sandur, Santosh
    Hasan, Syed K.
    CELLULAR SIGNALLING, 2024, 114
  • [43] Mitocurcumin Utilizes Oxidative Stress to Upregulate JNK/p38 Signaling and Overcomes Cytarabine Resistance in Acute Myeloid Leukemia
    Gaur, Tarang
    Hasan, Syed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S291 - S291
  • [44] DRUG RESISTANCE Overcoming resistance in acute myeloid leukaemia treatment
    Lokody, Isabel
    NATURE REVIEWS CANCER, 2014, 14 (07) : 453 - 453
  • [45] Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia
    Wang, Hanlin
    Luo, Guanghao
    Hu, Xiaobei
    Xu, Gaoya
    Wang, Tao
    Liu, Minmin
    Qiu, Xiaohui
    Li, Jianan
    Fu, Jingfeng
    Feng, Bo
    Tu, Yutong
    Kan, Weijuan
    Wang, Chang
    Xu, Ran
    Zhou, Yubo
    Yang, Jianmin
    Li, Jia
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [46] Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia
    Hanlin Wang
    Guanghao Luo
    Xiaobei Hu
    Gaoya Xu
    Tao Wang
    Minmin Liu
    Xiaohui Qiu
    Jianan Li
    Jingfeng Fu
    Bo Feng
    Yutong Tu
    Weijuan Kan
    Chang Wang
    Ran Xu
    Yubo Zhou
    Jianmin Yang
    Jia Li
    Nature Communications, 14
  • [47] Mutation analysis of BCL 10 in acute myeloid leukaemia
    Liu, TC
    Lin, PM
    Chang, JG
    Lee, JP
    Chen, TP
    Sue, YC
    Lin, SF
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) : 250 - 252
  • [48] Molecular mechanisms of drug resistance in acute myeloid leukaemia
    McLornan, Donal P.
    McMullin, Mary Frances
    Johnston, Patrick
    Longley, Daniel B.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (03) : 363 - 377
  • [49] Inhibited apoptosis and drug resistance in acute myeloid leukaemia
    Smith, BD
    Bambach, BJ
    Vala, MS
    Barber, JP
    Enger, C
    Brodsky, RA
    Burke, PJ
    Gore, SD
    Jones, RJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (04) : 1042 - 1049
  • [50] Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia
    Doyen, Jerome
    Italiano, Antoine
    Peyrade, Frederic
    Bouyer, Claude
    Thyss, Antoine
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (05) : 744 - 745
12345